Causes of exocrine pancreatic insufficiency other than chronic pancreatitis
L Kunovský, P Dítě, P Jabandžiev, M Eid… - Journal of Clinical …, 2021 - mdpi.com
Exocrine pancreatic insufficiency (EPI), an important cause of maldigestion and malnutrition,
results from primary pancreatic disease or is secondary to impaired exocrine pancreatic …
results from primary pancreatic disease or is secondary to impaired exocrine pancreatic …
[HTML][HTML] Colorectal cancer screening: 20 years of development and recent progress
M Zavoral, S Suchanek, O Majek, P Fric… - World journal of …, 2014 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the second most common cancer in Europe and its incidence is
steadily increasing. This trend could be reversed through timely secondary prevention …
steadily increasing. This trend could be reversed through timely secondary prevention …
Geographic variation of mutagenic exposures in kidney cancer genomes
International differences in the incidence of many cancer types indicate the existence of
carcinogen exposures that have not yet been identified by conventional epidemiology make …
carcinogen exposures that have not yet been identified by conventional epidemiology make …
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
M Svoboda, J Sana, P Fabian, I Kocakova… - Radiation …, 2012 - Springer
Background Rectal cancer accounts for approximately one third of all colorectal cancers
(CRC), which belong among leading causes of cancer deaths worldwide. Standard …
(CRC), which belong among leading causes of cancer deaths worldwide. Standard …
Regional geographic variations in kidney cancer incidence rates in European countries
P Li, A Znaor, I Holcatova, E Fabianova, D Mates… - European urology, 2015 - Elsevier
Context Marked unexplained national variations in incidence rates of kidney cancer have
been observed for decades in Europe. Objective To investigate geographic variations at the …
been observed for decades in Europe. Objective To investigate geographic variations at the …
Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours
F Malir, M Louda, V Ostry, J Toman, N Ali, Y Grosse… - Mycotoxin …, 2019 - Springer
Abstract The Czech Republic occupies the first place in the world in the frequency of renal
and other urinary tract tumours, but their aetiology is unknown. To explore whether …
and other urinary tract tumours, but their aetiology is unknown. To explore whether …
Quality of life of patients after total laryngectomy: the struggle against stigmatization and social exclusion using speech synthesis
In this article, we deal with the problem of potential stigmatization and social exclusion of
people that have voice/speech problems due to neck cancer, especially those who have lost …
people that have voice/speech problems due to neck cancer, especially those who have lost …
Current screening strategies for pancreatic cancer
P Vanek, O Urban, V Zoundjiekpon, P Falt - Biomedicines, 2022 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is a dreaded malignancy with a dismal 5-year
survival rate despite maximal efforts on optimizing treatment strategies. Radical surgery is …
survival rate despite maximal efforts on optimizing treatment strategies. Radical surgery is …
Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening
S Suchanek, O Majek, G Vojtechova… - European Journal of …, 2014 - journals.lww.com
The incidence and mortality of colorectal cancer (CRC) in the Czech Republic is significant.
The National CRC Screening Program started in 2000 and was further enhanced in 2009. In …
The National CRC Screening Program started in 2000 and was further enhanced in 2009. In …
SWATH-MS analysis of FFPE tissues identifies stathmin as a potential marker of endometrial cancer in patients exposed to tamoxifen
L Janacova, J Faktor, L Capkova… - Journal of proteome …, 2020 - ACS Publications
A specific form of endometrial cancer (EC) can develop in breast cancer patients previously
treated with tamoxifen (ET), an antagonist of estrogen receptor (ER) that inhibits proliferation …
treated with tamoxifen (ET), an antagonist of estrogen receptor (ER) that inhibits proliferation …